Business · 16/10/2026
Viatris Receives U.S. FDA Approval for RYZUMVI for Presbyopia Treatment
Viatris Inc. has received FDA approval for RYZUMVI, a treatment for presbyopia, from the U.S. Food and Drug Administration.
Business · 16/10/2026
Viatris Inc. has received FDA approval for RYZUMVI, a treatment for presbyopia, from the U.S. Food and Drug Administration.